Stable but Not Safe: Hidden Cardiac Risk in Clinically Quiet Patients

This chapter discuss cardiac safety in stable patients, meaning patients who look clinically fine but still carry cardiovascular risk inside the body. Even without chest pain or shortness of breath, subclinical cardiac changes can already happen. Echocardiography findings show that hidden remodeling and functional changes can predict later events like coronary heart disease, stroke, heart failure, and cardiovascular death. Because of that, cardiac safety should not depend only on symptom checking, but also on early screening tools such as myocardial work indices, strain analysis, and ambulatory blood pressure monitoring. Blood pressure control is a key part of safety. Many studies suggest that abnormal circadian blood pressure patterns (non-dipping or riser type) are linked with left atrial stiffness, ventricular dysfunction, and higher biomarker levels, which may lead to worse prognosis even in stable phase. Intensive blood pressure treatment shows overall benefit in reducing cardiovascular outcomes, while adverse events are slightly higher but mostly manageable, so the benefit is still bigger than harm in many stable patients. However, the approach must be personalized, especially in older adults or patients with metabolic risk where hypotension risk can increase. Cardiac safety is also supported by vascular protection. Endothelial function assessment is important because endothelial dysfunction is an early trigger of cardiovascular events, and therapies improving endothelial function can support long-term safety. Lifestyle programs like supervised exercise and structured cardiac rehabilitation improve autonomic balance, exercise tolerance, and blood pressure variability, showing safe and helpful outcomes in stable hypertension, coronary artery disease, and heart failure Overall, stable patients still need active monitoring, multi-factor management, and individualized decision-making to maintain long-term cardiac safety.